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doi:10.1016/j.kjms.2012.04.003Abstract Several studies have found that metabolic syndrome and uric acid level are related
to abnormal liver function test results. The aim of this study was to explore the associations of
risk factors [including blood pressure, blood sugar, total cholesterol, triglyceride, uric acid,
waist circumference and body mass index (BMI) measurements] with abnormal liver function
in the Taiwanese population.In total, 11,411 Taiwanese adults were enrolled in this study.
Blood pressure was assessed according to the Seventh Report of the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria, fasting
blood sugar level according to the Bureau of Health Promotion, Department of Health,
R.O.C., criteria, total cholesterol and triglyceride levels according to the Third Report of
the National Cholesterol Education Program Adult Treatment Panel III criteria, BMI according
to the Asia-Pacific criteria, and waist circumference according to the Revised Diagnosticof Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st
.com (C.-Y. Dai).
vier Taiwan LLC. All rights reserved.
Factors related to abnormal aminotransferase level 471Criteria of Metabolic Syndrome in Taiwan. The prevalence of a past history of hypertension and
diabetes mellitus was 17.7% and 6.5%, respectively, and the rates of abnormal measurements
of blood pressure, BMI, waist circumference, fasting blood sugar, triglyceride, total choles-
terol, uric acid (male/female), aspartate aminotransferase (AST), and alanine aminotrans-
ferase (ALT) were 76.2%, 67.6%, 40.0%, 28.6%, 30.6%, 57.3%, 37.9%/21.9%, 14.6% and 21.3%,
respectively. Multivariate analysis showed that waist circumference, BMI, serum uric acid,
blood sugar, and triglyceride levels were related to abnormal AST and ALT (p< 0.05), but
the odds ratio for waist circumference was larger than that for BMI. In conclusion, waist
circumference, BMI, serum uric acid, blood sugar, and triglyceride levels are important risk
factors for abnormal AST and ALT readings in Taiwanese adults. Waist circumference might
be a better indicator of risk of abnormal liver function than BMI.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Taiwan, like some developed countries, is gradually
entering an era of an aging society [1], and hence the
prevalence rates of chronic diseases such as cardiovascular
disease and so on are also gradually increasing, especially
in the elderly [2]. In addition, diseases related to obesity or
higher body mass index (BMI) and metabolic syndrome (MS)
are also gradually becoming the focus of more attention in
the elderly population in Taiwan, because these conditions
are becoming important public health issues.
It has been reported in some studies that obesity, BMI orMS
is related to abnormal liver function test results [3e6]. In our
previous small-scale study,we reported thatMS, as defined by
both the modified Third Report of the National Cholesterol
Education Program Adult Treatment Panel III (NCEP ATP-III)
and the International Diabetes Federation criteria for
Asians, was related to abnormal liver function test results in
patients with nonchronic hepatitis B and chronic hepatitis C
[7]. In addition, we suggested that the possible mechanism
underlying the associations between obesity and MS and
abnormal hepatic enzymes might be related to insulin resis-
tance (IR), which could lead to hepatic steatosis or even
nonalcoholic steatohepatitis (NASH) [8]. However, the rela-
tionship between uric acid level and liver function test results
is still unclear. In one study, it was found that hyperuricemia
was related to nonalcoholic fatty liver disease (NAFLD) and
was identified as a risk factor for elevation in NAFLD [9].
The Taiwanese Bureau of National Health Insurance
(BNHI) provides a free health examination including labo-
ratory tests of metabolic factors for adults older than 40
years. As some metabolic characteristics are known to be
related to some chronic diseases, the aim of this study was
to explore the associations between blood pressure and
blood sugar, total cholesterol, triglyceride, and uric acid
levels, waist circumference, and BMI, with liver function
test results in Taiwanese adults who were examined under
the adult health examination service of the BNHI.Methods
Patients
In this study, Taiwanese adults who had undergone examina-
tion under the health examination service of the BNHIbetween September 2005 and June 2009were retrospectively
enrolled from the database of the Department of Preventive
Medicine of Kaohsiung Municipal Hsiaokang Hospital.
According to the regulations of the BNHI set down in 1996,
Taiwanese adults aged between 40 and 64 years are able to
receive this examination every 3 years, and those aged 65
years or over, or those with poliomyelitis who are older than
35 years, are able to receive this examination every year. The
examination includes taking a medical history, conducting
a physical examination, taking a complete cell count,
measurement of fasting sugar, total cholesterol, triglyceride,
aspartate aminotransferase (AST)/alanine aminotransferase
(ALT), serum urine nitrogen/creatinine, and albumin/glob-
ulin levels, and routine examination of the urine [10].
The data recorded during this examination included age,
gender, height, weight, and related medical history, such as
hypertension and diabetes mellitus. A history of hyperten-
sion was defined as positive in individuals taking antihyper-
tensive drugs to control blood pressure, and a history of
diabetes mellitus was defined as positive in those who had
received drug or insulin therapy to control blood sugar levels.
Patients with a severe systemic disease such as congestive
heart failure controlled with drugs, renal failure with or
without dialysis, and severe hepatic or decompensated liver
disease; those with a history of chronic hepatitis B or chronic
hepatitis C with hepatotoxicity or nephrotoxicity who were
taking medication, and those with history of leukemia/
lymphomaor any other hematological diseasewere excluded
from this study. Ultimately, 11,411 participants in total were
enrolled.This studywas approved by the Institutional Review
Board of Kaohsiung Municipal Hsiaokang Hospital.Data collection
Height, weight, and waist circumference measurements for
all participants were recorded upon examination, and fasting
sugar, total cholesterol, triglyceride, AST, ALT, and uric acid
levelsweremeasured after fasting for at least 12 hours; these
data were included for analysis in this study.Blood samples
were transported and sent for examination within 4 hours.
BMI (kg/m2) was calculated asweight/(height)2. Blood pres-
sure was measured in a sitting position, and no drugs were
taken during the fasting period. The cut-off values used in
this study were as follows: systolic blood pressure and dia-
stolic blood pressure, 120/80 mmHg (according to the
Seventh Report of the Joint National Committee on
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Blood Pressure criteria) [11]; fasting sugar, 5.56 mmol/l (100
mg/dL) (according to the Bureau of Health Promotion,
Department of Health, R.O.C. criteria) [12]; lipid profile:
total cholesterol, 5.17 mmol/l (200 mg/dL) (according to the
NCEP-ATP III criteria) [13]; triglyceride, 1.71 mmol/l (150
mg/dL) [13]; uric acid: 416.36 mmol/l (7mg/dL) formales and
356.88 mmol/l (6 mg/dL) for females [14]; albumin, 3.5 g/dl;
AST, 0.56 mkat/l (42IU/l); and ALT, 0.58 mkat/l (40IU/l).BMI and waist circumference
A BMI equal to or greater than 23 kg/m2 was defined as
overweight according to the Steering Committee of the
Regional Office for the Western Pacific Region of the World
Health Organization, the Asian standards for BMI (kg/m2)
being as follows: underweight< 18.5; normal 18.5e22.9;
overweight 23e24.9; obese stage I 25e29.9; and obese
stage II  30 [15]. Waistcircumferencewas measured at the
mid-point between the upper point of the bilateral iliac
crest and the inferior margin of the rib cage in the hori-
zontal plane at the end of expiration while patients stood
with legs akimbo. Abdominal obesity in our study was
defined according to the guidelines of the Bureau of Health
Promotion as a waist circumference of  90 cm for Taiwa-
nese men and  80 cm for Taiwanese women [16].Table 1 Basic characteristics of the individuals included in the
All participants
Case number [n (%)] 11,411 (100.0)
Mean age (mean SD) 51.95 6.81
History of diabetes mellitus [n (%)] 742 (6.5)
History of hypertension [n (%)] 2,016 (17.7)
Mean blood pressure
Systolic (mean SD) 127.00 19.38
Diastolic (mean SD) 78.07 11.38
Blood pressure  120/80 mmHg [n (%)] 7,666 (67.2)
Mean body mass index (mean SD) 24.83 3.06
Body mass index  23 kg/m2 [n (%)] 7,709 (67.6)
Mean waist circumference (mean SD) 81.68 10.24
Waist circumference [n (%)] 4,567 (40.0)a
Fasting glucose  5.56 mmol/l [n (%)] 3,265 (28.6)
Triglyceride  1.71 mmol/l [n (%)] 3,494 (30.6)
Total cholesterol  5.17 mmol/l [n (%)] 6,543 (57.3)
Uric acid 3,224 (28.3)d
Abnormal liver function
AST (mkat/l) (mean SD) 0.45 0.29
ALT (mkat/l) (mean SD) 0.47 0.22
AST > 0.56 mkat/l 1,664 (14.6)
ALT > 0.58 mkat/l 2,436 (21.3)
Results are given as mean standard deviation (SD).
Upper limits of normal: AST Z 0.56 mkat/l; ALT Z 0.58 mkat/l.
ALTZ alanine aminotransferase; ASTZ aspartate aminotransferase.
a Male  90 cm, female  80 cm.
b Male  90 cm.
c Female  80 cm.
d Male  416.36 mmol/l, female  356.88 mmol/l.
e Male  416.36 mmol/l.
f female  356.88 mmol/l.Statistical analysis
Frequencies were compared between groups using the Chi-
square test with Yates’s correction or Fisher’s exact test;
group means were compared using the Student t test or the
ManneWhitney U-test. All of these tests were two-sided,
andthesignificance level was set ataZ 0.05. Multivariate
logistic regression analysis was used to evaluate the odds
ratios and 95% confidence intervals by age, gender, BMI,
waist circumference, blood pressure, blood sugar, uric
acid, total cholesterol, and triglyceride levels. Linear
regression analysis was used between BMI or waist
circumference and AST and ALT values. Analyses were
performed using the SPSS statistical package (SPSS Inc.,
Chicago, IL, USA).
Results
A total of 11,411 participants were enrolled in this study,
4,538 (39.8%) males and 6,873 (60.2%) females, with a mean
age of 51.95 6.81 years (males 54.48 7.01, females
51.61 6.65; p< 0.001). The basic characteristics of all the
participants are presented in Table 1. The prevalence of
a past history of hypertension and diabetes mellitus was
17.7% and 6.5%, respectively, and the rates of abnormal
measurements of blood pressure, BMI, waist circumference,study.
Male Female p
4,538 (39.8) 6,873 (60.2)
54.48 7.01 51.61 6.65 < 0.001
380 (8.4) 362 (5.3) < 0.001
922 (20.3) 1,094 (15.9) < 0.001
127.32 18.67 126.78 19.83 0.14
79.11 11.44 77.37 11.29 < 0.001
3,135 (69.1) 4,531 (65.9) < 0.001
25.41 3.40 24.45 3.68 < 0.001
3,457 (76.2) 4,252 (61.9) < 0.001
87.69 8.94 78.01 9.17 < 0.001
1,816 (40.0)b 2,751 (40.0)c 0.99
1,533 (34.2) 1,712 (24.9) < 0.001
1,874 (41.3) 1,620 (23.6) < 0.001
2,490 (54.9) 4,053 (59.0) < 0.001
1,722 (37.9)e 1,502 (21.9)f < 0.001
0.50 0.36 0.42 0.23 < 0.001
0.56 0.40 0.41 0.34 < 0.001
879 (52.8) 785 (47.2) < 0.001
1,397 (57.3) 1,039 (42.7) < 0.001
Factors related to abnormal aminotransferase level 473fasting sugar, triglyceride, total cholesterol, uric acid
(male/female), AST, and ALT were 76.2%, 67.6%, 40.0%,
28.6%, 30.6%, 57.3%, 37.9%/21.9%,14.6% and 21.3%,
respectively. With the exception of systolic blood pressureTable 2 Comparison of the characteristics of patients with nor
AST
Normal Abnorm
Case number [n (%)] 9,747 (85.4) 1,664 (14.
Mean age (mean SD) 51.81 6.78 52.80 6.9
Gender
Male [n (%)] 3,569 (80.6) 879 (19.4)
Female [n (%)] 6,088 (88.6) 785 (11.4)
Mean fasting sugar (mean SD) 5.56 1.92 6.08 2.37
Fasting sugar< 5.56 mmol/l 7,185 (88.2) 961 (11.8)
Fasting sugar 5.56 mmol/l 2,562 (78.5) 703 (21.5)
History of diabetes mellitus
No [n (%)] 9,156 (85.8) 1,513 (14.
Yes [n (%)] 591 (76.9) 151 (20.4)
Mean blood pressure
Systolic (mean SD) 126.87 19.43 127.75 1
Diastolic (mean SD) 77.89 11.39 79.10 11
Systolic/diastolic blood pressure
< 120/80 mmHg 3,238 (86.5) 507 (13.5)
 120/80 mmHg 6,509 (85.9) 1,157 (15.
History of hypertension
No [n (%)] 8,126 (86.5) 1,269 (13.
Yes [n (%)] 1,621 (80.4) 395 (16.9)
Mean triglyceride (mean SD) 1.41 1.24 2.07 2.36
Triglyceride< 1.71 mmol/l 6,990 (88.3) 927 (11.7)
Triglyceride 1.71 mmol/l 2,757 (78.9) 737 (21.1)
Mean total cholesterol (mean SD) 5.39 0.99 5.40 1.20
Total cholesterol< 5.17 mmol/l 4,155 (85.4) 713 (14.6)
Total cholesterol 5.17 mmol/l 5,592 (85.5) 951 (14.5)
Mean waist circumference
(mean SD)
81.08 9.96 86.43 10
Waist circumference
Male
< 90 cm [n (%)] 2,296 (62.7) 426 (48.5)
 90 cm [n (%)] 1,363 (37.3) 453 (51.5)
Female
< 80 cm [n (%)] 3,794 (62.3) 381 (36.7)
 80 cm [n (%)] 2,294 (37.7) 457 (58.2)
Mean BMI (mean SD) 24.60 3.47 26.20 4.0
< 23 kg/m2 [n (%)] 3,341 (34.3) 361 (21.7)
 23 kg/m2 [n (%)] 6,406 (65.7) 1,303 (78.
Mean uric acid 333.09 91.00 378.89 1
Male
< 416.36 mmol/l [n (%)] 2,367 (64.7) 449 (51.1)
 416.36 mmol/l [n (%)] 1,292 (35.3) 430 (48.9)
Female
< 356.88 mmol/l [n (%)] 4,879 (80.1) 492 (67.2)
 356.88 mmol/l [n (%)] 1,209 (19.9) 293 (37.3)
Results are means standard deviations (SD).
ALTZ alanine aminotransferase; ASTZ aspartate aminotransferase.
a ManneWhitney U test.and waist circumference, significant between-gender
differences were observed (Table 1).
Table 2 shows the results of analysis of AST and ALT,
from which it can be seen that systolic blood pressure wasmal and abnormal AST and ALT levels.
ALT
al p Normal Abnormal p
6) 8,975 (78.7) 2,436 (21.3)
8 < 0.001 51.97 6.83 51.89 6.74 0.57
< 0.001 3,141 (69.2) 1,379 (30.8) < 0.001
5,834 (84.9) 1,039 (15.1)
< 0.001 5.52 1.89 6.07 2.30 < 0.001
< 0.001 6,742 (82.8) 1,404 (17.2) < 0.001
2,233 (68.4) 1,032 (31.6)
2) < 0.001 8,440 (79.1) 2,229 (20.9) < 0.001
535 (72.1) 207 (27.9)
9.08 0.09 126.78 19.42 127.79 19.20 0.22
.78 < 0.001 77.74 11.36 79.29 11.40 < 0.001
0.03 3,010 (80.4) 735 (19.6) 0.002
1) 5,965 (77.8) 1,701 (22.2)
5) < 0.001 7,523 (80.1) 1,872 (19.1) < 0.001
1,452 (70.2) 564 (28.0)
< 0.001a 1.46 1.23 2.10 2.07 < 0.001
< 0.001 6,665 (84.2) 1,252 (15.8) < 0.001
2,310 (66.1) 1,184 (33.9)
0.80 5.37 0.98 3.14 1.14 < 0.001
0.87 3,923 (80.6) 945 (19.4) < 0.001
5,052 (77.2) 1,491(22.8)
.67 < 0.001 80.38 9.82 87.31 9.89 < 0.001
< 0.001 2,059 (65.6) 663 (47.5) < 0.001
1,082 (34.4) 734 (52.5)
< 0.001 3,741 (64.1) 381 (36.7) < 0.001
2,093 (35.9) 658 (63.3)
5 < 0.001 24.31 3.47 26.55 3.76 < 0.001
< 0.001 3,297 (36.7) 405 (16.6) < 0.001
3) 5,678 (63.3) 2,031 (83.4)
05.28 < 0.001 328.92 89.81 380.08 99.93 < 0.001
< 0.001 2,056 (65.6) 760 (54.4) < 0.001
1,085 (34.5) 637 (45.6)
< 0.001 4,738 (81.2) 633 (60.9) < 0.001
1,096 (18.8) 406 (39.1)
474 M.-H. Hsieh et al.not related to abnormal AST and ALT levels. With the
exceptions that the total cholesterol level was related only
to an abnormal ALT level and mean age only to an abnormal
AST level, all other items were found to be significantly
related to both abnormal AST and ALT levels.
Multivariate logistic analysis was also performed for AST
and ALT; the results are presented in Table 3, from which it
can be seen that fasting sugar level, triglyceride level,
waist circumference, uric acid level, and BMI were signifi-
cantly related, with an odds ratio of more than 1, to AST
and ALT. Regarding gender differences, males were found
to have a higher risk of abnormality in the levels of both AST
and ALT. BMI was observed to be a significant risk factor of
abnormal levels of both AST (odds ratio 1.06; 95% confi-
dence interval 1.04e1.08) and ALT (odds ratio 1.54; 95%
confidence interval 1.34e1.76). Total cholesterol level
(odds ratio 0.85; 95% confidence interval 0.76e0.95) was
found to be significantly related only to an abnormal AST
level. In addition, age was found to be a significant factor
related to an abnormal ALT level (odds ratio 0.967; 95%
confidence interval 0.969e0.983).
Linear regression between BMI or waist circumference
and AST and ALT was performed. The standardized coeffi-
cients of BMI and waist circumference for AST were 0.123
(p< 0.001) and 0.165 (p< 0.001), respectively, and the
standardized coefficients of BMI and waist circumference
for ALT were 0.272 (p< 0.001) and 0.306 (p< 0.001),
respectively (data not shown).Discussion
Tan et al. [17] reported the results of a study in 2001 of
2,944 people from central Taiwan, which indicated that
21.3% and 23.6% of the individuals had a high systolic andTable 3 Multivariate logistic analysis of factors associated with
Factor Comparison
Abnormality in AST
Gender MaleZ 0, femaleZ 1
Fasting sugar < 5.56 mmol/lZ 0,  5.56 mmol/lZ 1
Total cholesterol < 5.17 mmol/lZ 0,  5.17 mmol/lZ 1
Triglyceride < 1.71 mmol/lZ 0,  1.71 mmol/lZ 1
Waist circumference Male< 90 cm/female< 80 cm Z0,
male 90 cm/female  80 cmZ 1
Uric acid Male< 416.36 mmol/l/female  356.88 mm
male 416.36 mmol/l/female  356.88 mm
Body mass index < 23 kg/m2Z 0,  23 kg/m2Z 1
Abnormality in ALT
Age By increases of 1 year
Gender MaleZ 0, femaleZ 1
Fasting sugar < 5.56 mmol/l Z 0, 5.56 mmol/l Z 1
Triglyceride < 1.71 mmol/l Z 0, 1.71 mmol/l Z 1
Waist circumference Male< 90 cm/female< 80 cmZ 0,
male  90 cm/female  80 cmZ 1
Uric acid Male< 416.36 mmol/l/female  356.88 mm
male 416.36 mmol/l/female  356.88 mm
Body mass index < 23 kg/m2Z 0,  23 kg/m2Z 1
ALTZ alanine aminotransferase; ASTZ aspartate aminotransferase.diastolic blood pressure, respectively; 19.7% were hyper-
uricemic; 40.0% had raised total cholesterol levels, and
13.7% were hypertriglyceridemic.
Huang et al. [18] also reported the prevalence rates of
a history of hypertension and diabetes mellitus to be 17.9%
and 5.6%, respectively, and the rates of abnormal blood
pressure, fasting sugar, total cholesterol, triglyceride,
fasting sugar, and uric acid measurements to be 39.7%,
10.9%, 16.8%, 14.3%, 10.9% and 6.5%, respectively, for 995
southern Taiwanese adults who were examined by the
health examination service of the BNHI between 2000 and
2001. The prevalence rates of a history of hypertension and
diabetes mellitus reported by Huang et al. were similar to
those obtained in our study, but the rates of abnormal
blood pressure and fasting sugar, total cholesterol,
triglyceride, fasting sugar, and uric acid levels reported in
the two aforementioned studies were lower than those
obtained in our study.
From the data reported by the Ministry of the Interior,
Taiwan, R.O.C., the percentage of people over 40 years of
age in 2000 was 36.31%, but in 2005 was 41.29% [19]; hence,
we believe that the results discussed above might be
a reflection of the gradually aging society in Taiwan, and
the rate of abnormal results for many of the measurements
discussed above may also gradually increase.
In previous studies, it has been reported that higher BMI
values and hyperlipidemia are associated with hepatic
steatosis [20, 21]. Accumulation of triglyceride in hepato-
cytes increases fatty acid oxidation, and when this occurs in
the presence of mitochondrial abnormalities (one example
of a ‘second hit’), this leads to the formation of free
radicals, with consequent cell injury, abnormal liver func-
tion presentation, inflammation, and fibrosis [22]. On the
other hand, insulin resistance is a particular danger and can
lead to mitochondrial damage, intracellular beta-oxidation,AST and ALT.
Odds ratio 95% confidence interval p
0.66 0.59e0.74 < 0.001
1.58 1.41e1.77 < 0.001
0.85 0.76e0.95 0.005
1.42 1.26e1.59 < 0.001
1.21 1.05e1.40 < 0.001
ol/l Z 0,
ol/l Z 1
1.59 1.42e1.78 < 0.001
1.06 1.04e1.08 < 0.001
0.976 0.969e0.983 < 0.001
0.48 0.44e0.53 < 0.001
1.76 1.59e1.94 < 0.001
1.74 1.58e1.93 < 0.001
1.74 1.58e1.93 < 0.001
ol/l Z 0,
ol/l Z 1
1.53 1.38e1.70 < 0.001
1.54 1.34e1.76 < 0.001
Factors related to abnormal aminotransferase level 475and fat depositionwithin hepatocytes[23], inducing the
destruction of hepatocytes and abnormal increases in
hepatic enzyme levels. In our study, abnormal AST and ALT
levels were found to be related to uric acid, triglyceride,
and fasting sugar levels and male gender, and in our
previous small-scale study, MS was identified as being
related to abnormal AST and ALT levels [7]. We therefore
consider it reasonable to propose that components of MS,
such as waist circumference, triglyceride level, and fasting
sugar level, are related to abnormal AST and ALT levels.
A higher BMI value and obesity might have an influence on
MS similar to that of hepatic steatosis, and even NASH,
especially in cases of insulin resistance [8]. In our study, BMI
was found to be related to abnormal AST and ALT levels,
a result that was also obtained in our previous small-scale
study [7]. In addition, waist circumference, one component
ofMS, is an indicator of obesity, andwe therefore believe that
a larger waist circumference might be related to abnormal
liver function via a mechanism similar to that of a higher BMI
value, which might be related to insulin resistance and NASH,
and may explain why waist circumference was found to be
related to abnormal AST and ALT levels in our study. In our
study, BMI and waist circumference were found to be related
to AST and ALT, and the odds ratio and standardized coeffi-
cients forwaist circumferencewere larger than those for BMI.
Owing to the definition of BMI, a higher BMI is not always
indicative of central obesity, even though BMI is related to MS
[7]. Therefore, we can suppose that waist circumference
might be a more suitable indicator of abnormal liver function
than BMI, and we encourage the measurement of waist
circumference in health examinations.
Uric acid level has been reported to be related to NAFLD
and an elevated ALT level [9], and both hyperuricemia and
insulin resistance with hyperinsulinemia have been found to
be related to NAFLD [24]. In addition, hyperuricemia has
been found to be related to a greater risk of MS [25]. The
mechanism by which uric acid level is related to abnormal
liver function is not clear: uric acid might cause MS, or even
the progression of NAFLD to NASH, on the basis of which an
abnormal liver function test would result; this possible
mechanism should be investigated in future studies.
Blood pressure was found to be significantly related to
abnormal liver function in univariate analysis, but not in
multivariate analysis, and there are no previous reports of
blood pressure being observed to be associated with an
abnormal liver function test result. Therefore, we believe
that blood pressure is not related to an abnormality in AST
and ALT levels. In addition, total cholesterol level was found
to be unrelated to only AST in univariate analysis and related
only to AST in multivariate logistic analysis in our study.
Because total cholesterol includes high-density lipoproteins,
low-density lipoproteins, triglyceride, and so on, we believe
that it is not suitable as an indicator of liver function. Finally,
age was found not to be associated with ALT level only in
univariate analysis, and not to be associated with AST level
only in multivariate analysis, and age was not a suitable
predictor of risk of abnormal liver function.
The limitation of this study was that all of our partici-
pants underwent a health examination through the BNHI, so
our results only reflect persons equal to or older than 35
years, and we do not have any results for persons younger
than 35 years.In conclusion, the prevalence of abnormal blood pres-
sure, fasting sugar, total cholesterol, triglyceride, and uric
acid has been gradually increasing in recent years, and we
believe that this is related to the gradual aging of society in
Taiwan. Waist circumference, BMI, serum uric acid, blood
sugar, and triglyceride levels are important risk factors for
abnormal AST and ALT in Taiwanese adults. We believe
waist circumference to be a better indicator of risk of
abnormal liver function than BMI.Acknowledgments
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